Parabon Nanolabs

Parabon NanoLabs is a privately-held US biotech firm pioneering the integration of computation and genetics to create next-generation DNA-based products. The company has a dual focus: a therapeutics-oriented DNA nanotech platform for drug design and a highly visible forensic services division offering DNA phenotyping, genetic genealogy, and kinship analysis to law enforcement. While its forensic services generate public case studies and likely early revenue, its therapeutic platform appears to be in a pre-clinical or research-stage development. Parabon's unique position bridges the biotechnology and forensic science markets, though it faces distinct challenges in each domain.

Proprietary computational design software (inSēquio) for engineering synthetic DNA nanostructures, combined with an integrated forensic analysis suite (Snapshot®) for DNA phenotyping, genetic genealogy, and kinship analysis.

In forensics, Parabon competes with other specialized genetic genealogy firms like Othram and Bode Technology, as well as internal lab capabilities at the FBI. In DNA nanotech/software, it faces competition from DNA synthesis giants (Twist Bioscience, IDT) offering design tools and broader bioinformatics software platforms from larger life science tech companies.